- Home
- SOHO vs APTO Comparison
SOHO vs APTO Comparison
Compare SOHO & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- APTO
- Stock Information
- Founded
- SOHO 2004
- APTO 1986
- Country
- SOHO United States
- APTO Canada
- Employees
- SOHO N/A
- APTO N/A
- Industry
- SOHO Real Estate Investment Trusts
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOHO Real Estate
- APTO Health Care
- Exchange
- SOHO Nasdaq
- APTO Nasdaq
- Market Cap
- SOHO 16.1M
- APTO 13.2M
- IPO Year
- SOHO 2004
- APTO N/A
- Fundamental
- Price
- SOHO $0.83
- APTO $0.16
- Analyst Decision
- SOHO Hold
- APTO Strong Buy
- Analyst Count
- SOHO 1
- APTO 3
- Target Price
- SOHO $1.50
- APTO $4.33
- AVG Volume (30 Days)
- SOHO 45.1K
- APTO 17.4M
- Earning Date
- SOHO 03-13-2025
- APTO 03-25-2025
- Dividend Yield
- SOHO N/A
- APTO N/A
- EPS Growth
- SOHO N/A
- APTO N/A
- EPS
- SOHO N/A
- APTO N/A
- Revenue
- SOHO $179,860,606.00
- APTO N/A
- Revenue This Year
- SOHO N/A
- APTO N/A
- Revenue Next Year
- SOHO $0.70
- APTO N/A
- P/E Ratio
- SOHO N/A
- APTO N/A
- Revenue Growth
- SOHO 3.98
- APTO N/A
- 52 Week Low
- SOHO $0.78
- APTO $0.13
- 52 Week High
- SOHO $1.54
- APTO $1.94
- Technical
- Relative Strength Index (RSI)
- SOHO 46.61
- APTO 42.85
- Support Level
- SOHO $0.78
- APTO $0.13
- Resistance Level
- SOHO $0.86
- APTO $0.26
- Average True Range (ATR)
- SOHO 0.04
- APTO 0.02
- MACD
- SOHO 0.01
- APTO -0.00
- Stochastic Oscillator
- SOHO 45.36
- APTO 24.69
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.